Divis Laboratories opened lower at ₹11,411.50, compared with its previous close of ₹11,485.00. In the last trading session on 13 Nov 2026, the stock traded between ₹11,350.50 and ₹11,645.50, with an average traded price of ₹11,497.77. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Divis Laboratories is now worth
₹ 23,622.00
Giving a profit of
₹ 13,622.00 (136.22%)
Note: Past profits do not guarantee future returns.
Rating by Refinitive from 26 Analysts
Today's Change
-43.00 (-0.37%)
Day High
₹11,645.50
Day Low
₹11,350.50
Day Open
₹11,411.50
Prev Close
₹11,485.00
Volume
5,36,553
Value Traded
₹616.92 Cr
1W Return
12.83%
1M Return
21.39%
3M Return
33.05%
6M Return
72.22%
1Y Return
75.49%
Market Cap (₹ Cr.)
3,03,749
PE Ratio
90.40
PB Ratio
16.89
Dividend Yield
0.26%
ROE
15.32%
ROCE
18.96%
Book Value (₹)
677.94
Face Value (₹)
2.00
EPS (TTM)
42.49
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
12.83%
6 Weeks
-
1 Month
21.39%
3 Months
33.05%
9 Months
85.00%
Divis Labs Q2FY27 net profit up 64%; peptide capacity expands
Net profit rose 64% YoY to ₹11,270 crore in Q2FY27. Revenue grew 35% YoY to ₹36,760 crore; EBITDA margin expanded to 42.60%. Custom synthesis contributed 62% of H1 revenue; generics 38%. Company installing multiple 3,000-litre SPPS lines to expand peptide capacity. Annual capex outlook maintained at ₹2,000 crore plus or minus 20%.
2 days agoDivis Laboratories shares worth ₹194.80 crore flag large trade on NSE
Approximately 2,13,394 shares of Divis Laboratories were flagged in a large-trade signal on NSE. Shares changed hands at ₹9,128.50, with a combined value of ₹194.80 crore. The signal is generated by a real-time trade-scanning system and is not a confirmed exchange-reported event. Buyer, seller, and broker identities are not available until the exchange discloses post-market reports.
24 days agoDivis Laboratories shares worth ₹23.49 crore change hands on BSE
A large-trade signal flagged approximately 24,994 shares of Divis Laboratories on BSE. Shares changed hands at ₹9400.00 per share, for a combined value of ₹23.49 crore. This is a real-time signal from trade-scanning activity, not a confirmed exchange-reported event. Official exchange disclosures on such activity are published only after market close.
1mo agoDivi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth
Divi's Laboratories posted a 65% YoY PAT surge to ₹902 crore in Q1FY27, with revenue rising 28% to ₹3,080 crore. The growth was supported by robust Custom Synthesis contributions and margin expansion, offsetting a forex loss of ₹7 crore compared to a gain last year.
3mo agoDivis Laboratories uploads Q1 FY27 earnings call audio for investors
Divis Laboratories Limited has made the audio recording of its Q1 FY27 earnings conference call available on its website. The call occurred on August 01, 2026, following a prior notice on July 24, 2026. The disclosure was filed with NSE and BSE under Regulation 30 of SEBI LODR, signed by Company Secretary M. Satish Choudhury.
3mo agoDivis Laboratories accepts retirement of two senior VPs
Divis Laboratories Ltd announced the retirement of Vice Presidents L. Ramesh Babu and D. Madhu Babu effective July 31, 2026. The filing, submitted under SEBI LODR Regulation 30, confirms both executives will cease to be Senior Management Personnel due to retirement, impacting procurement and projects divisions.
3mo agoNo contracts data.
| Contract | Days to Expiry | LTP | Change | Change % | Volume | OI | OI Chg % |
|---|---|---|---|---|---|---|---|
| DIVISLAB NOV FUT | 10 | 11,450.00 | -27.00 | -0.24 | 6,07,800 | 55,92,300 | 0.14 |
| DIVISLAB DEC FUT | 46 | 11,531.00 | -23.00 | -0.20 | 1,80,700 | 7,29,100 | 17.22 |
| DIVISLAB JAN FUT | 73 | 11,601.50 | -12.50 | -0.11 | 19,800 | 54,900 | 14.14 |
| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,880.00 | -0.27% | ₹4,51,074.97 | 41.20 | +8.54% | |
| ₹4,670.00 | -1.21% | ₹1,77,631.79 | 85.50 | +22.10% | |
| ₹2,424.00 | +1.00% | ₹1,30,971.68 | 97.10 | +145.03% | |
| ₹1,189.90 | -1.33% | ₹1,18,692.98 | 28.00 | +25.07% | |
| ₹1,380.00 | -0.48% | ₹1,15,185.88 | 42.00 | +12.23% | |
| ₹1,391.80 | -1.17% | ₹1,12,437.74 | 39.90 | -8.39% | |
| ₹2,640.00 | +0.05% | ₹1,09,043.90 | 48.10 | +16.30% | |
| ₹1,823.20 | +0.89% | ₹1,04,902.90 | 26.00 | +54.04% | |
| ₹1,980.30 | -1.72% | ₹90,557.13 | 17.60 | -2.64% | |
| ₹2,640.00 | -0.74% | ₹74,507.31 | 51.60 | +42.87% | |
| ₹5,114.00 | -3.55% | ₹61,145.54 | 30.50 | -11.33% | |
| ₹364.05 | -1.86% | ₹59,329.01 | 177.50 | -10.31% |
An investment of ₹10,000 made 5 years ago in Divis Laboratories is now worth
₹ 23,622.00
Giving a profit of
₹ 13,622.00 (136.22%)
Note: Past profits do not guarantee future returns.